SL-89.0591

SL-89.0591
Nazivi
	Preferisani IUPAC naziv 2-[3-[4-(5-hloro-2-metoksifenil)piperazin-1-il]propilamino]pyrimidin-4-karboksamid
	Drugi nazivi CHEMBL24981; SL 89.0591; SCHEMBL5597266; BDBM50160159; L013345
Identifikacija
3D model (Jmol)	interaktivna slika;
PubChem C ID	9909211;
	SMILES COC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCCNC3=NC=CC(=N3)C(=O)N; ; ; ; ; ;
Svojstva
Hemijska formula	C19H25ClN6O2
Molarna masa	404,90 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

SL-89.0591 je antagonist alfa adrenergičkog receptora.^[3]

Reference[уреди | уреди извор]

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Barry Kenny; Alan Collis; Alasdair Naylor; Michael Wyllie (2008). „Section Review Central & Peripheral Nervous Systems: α1-Adrenoceptor antagonists as treatments for benign prostatic hyperplasia”. Expert Opinion on Investigational Drugs. 4 (10): 915—923. doi:10.1517/13543784.4.10.915.